Collectively, these studies demonstrated that CML induced extensive intestinal remodeling characterized by the IL-9 regulated expansion of mucosal mast, tuft and goblet cells. Here, IL9 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.